2-(4-Ethyl-2,3-dioxopiperazin-1-yl)-N-3-(trifluoromethyl)phenylacetamide is a specialized organic compound featuring a dioxopiperazine core and a trifluoromethylphenylacetamide moiety. Its structural design confers potential advantages in medicinal chemistry, particularly as an intermediate for bioactive molecules. The presence of the trifluoromethyl group enhances lipophilicity and metabolic stability, while the dioxopiperazine scaffold may contribute to conformational rigidity, improving binding affinity in target interactions. This compound is of interest in pharmaceutical research for its potential applications in drug discovery, particularly in the development of enzyme inhibitors or receptor modulators. Its synthetic versatility allows for further derivatization, making it a valuable building block for exploring structure-activity relationships in biologically active compounds.